Kerry A. Waters

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat

E. Southam, D. Pemberton, L. Lacroix, 2008, Psychopharmacology.

Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat

G. Dawson, R. Dias, D. O'connor, 2005, Journal of psychopharmacology.

Behavioral and Neurochemical Alterations in Mice Deficient in Anaplastic Lymphoma Kinase Suggest Therapeutic Potential for Psychiatric Indications

Petr Znamenskiy, P. Whiting, J. Bilsland, 2008, Neuropsychopharmacology.

Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile

S. Ward, J. Atack, L. Lacroix, 2019, Journal of psychopharmacology.

Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat

S. Bate, D. Hutcheson, C. Reavill, 2008, Behavioural pharmacology.

Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment.

R. Young, J. Mancini, R. Friesen, 2010, Bioorganic & medicinal chemistry letters.

Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition

J. Kew, N. Upton, I. Hussain, 2012, Behavioural Brain Research.